The SLC22A12 gene helps the kidneys take back uric acid, a normal waste product, instead of losing too much in urine. If it does not work well, uric acid levels in the blood can be unusually low, a pattern called renal hypouricemia. Some people never notice symptoms, while others may develop kidney stones or kidney strain after intense exercise.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or direct activities in the body. Some genes carry the information needed to produce proteins, the parts of cells that do the work. Other genes mainly regulate when certain processes happen, where they happen, and how strongly they operate. Together, genes affect how the body develops and works, and they can shape how you respond to food, stress, or medications. If you want to go into this topic in more detail, you can find more in the LearnHub.
Overview
SLC22A12Gene function
What if the gene works
The SLC22A12 gene helps kidney cells move uric acid from urine back into the blood. This supports a healthy balance of uric acid in the body.
Risk
What if the gene does not work
Variants in the SLC22A12 gene can cause renal hypouricemia, with too much uric acid lost in urine. People have no symptoms while others develop kidney stones or kidney injury after exercise. Milder or more severe variants can influence this range.
Treatment
What does that mean for your treatment
For pathogenic variants in the SLC22A12 gene, treatment mainly aims to reduce kidney stress rather than reverse the gene change. Good hydration and avoiding very intense exercise are standard, and some people with previous exercise related kidney injury may be offered allopurinol to lower the chance of another episode. Drugs that increase uric acid loss are usually avoided.
Conditions associated with SLC22A12
Gene function
What if the gene works
Your kidneys constantly sort what to keep and what to remove in urine. The SLC22A12 gene helps with that sorting process by moving uric acid back into the body after it is filtered. This helps keep uric acid levels in a healthy range.
This gene makes a transporter in the kidney that pulls uric acid back from forming urine. That return step helps your body keep uric acid in a steady range instead of losing too much in urine.
By reclaiming part of the filtered uric acid, this gene influences how much stays in your bloodstream. This is why the SLC22A12 gene function is closely tied to normal uric acid handling in the body.
Its transporter works like a swap system at the surface of kidney cells, moving uric acid in while other small molecules move out. This exchange helps the return process run in a controlled way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can more substantially change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC22A12 gene can change the shape or amount of its urate transporter, so less of the protein reaches the kidney cell surface or it moves urate less effectively. This is how SLC22A12 gene variants affect urate transport at the cellular level. Some variants cause only a partial loss of activity, while more disruptive variants can leave little or no transport function. Stronger changes, especially in both gene copies, are linked to earlier or more noticeable renal hypouricemia.
How variants are linked to conditions
Pathogenic variants in the SLC22A12 gene cause renal hypouricemia type 1, an inherited condition in which blood uric acid levels are unusually low. Some people have no symptoms, while others are more likely to develop kidney stones or episodes of acute kidney injury after intense exercise. In this setting, a confirmed SLC22A12 gene variant can help establish the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some cases, though, a single well-characterized variant in a specific gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
For people with changes in the SLC22A12 gene, the main risk is not usually whether the gene change is present, but whether certain triggers lead to problems such as sudden kidney injury or kidney stones. Hard, short bursts of exercise, dehydration, and heat can raise that risk, so good hydration and avoiding extreme exertion when unwell can help lower the chance of complications.
Inheritance of SLC22A12 variants
SLC22A12-related renal hypouricemia is usually inherited in an autosomal recessive pattern. This means a person typically inherits one SLC22A12 gene variant from each parent, and parents who each carry one variant are often unaffected themselves. For each pregnancy, two carrier parents have a 25% chance of having a child with the condition, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without either variant. This SLC22A12 inheritance pattern applies to the well-established kidney condition linked to this gene.
What does my SLC22A12 result mean for my family?
For families, an SLC22A12 result usually matters most in a recessive way. Brothers, sisters, and future children could also carry the same gene change, and in some families a sibling may have the condition too. Parents are often healthy carriers, and other relatives may also carry the change without knowing it.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SLC22A12 gene, genetic testing for SLC22A12 variants reads your DNA from a blood, saliva, or cheek swab sample. It looks for changes linked with inherited low uric acid levels and can help confirm a suspected diagnosis when considered alongside symptoms and lab results.
When should I consider getting a genetic test?
Consider testing for SLC22A12 if you have repeated blood tests showing very low uric acid, especially with kidney stones, blood in the urine, or sudden kidney problems after hard exercise. Testing can also help when these problems run in your family or when a doctor suspects inherited low uric acid levels.
A genetic result is only one part of your health story
A genetic result can be informative, but what it can tell you varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may absorb, move, break down, or respond to a drug in different ways. These differences are common and can influence how well a medicine works or how sensitive someone is to side effects. Genetics is one part of the picture, along with age, kidney and liver function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It focuses on relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes influence either how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. To explore this subject further, more information is available in the LearnHub.
Drugs influenced by the SLC22A12 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choices, so questions about your medicines, side effects, or gout treatment are best discussed with your doctor. Research on SLC22A12 has looked at whether gene changes may affect uric acid handling and response to some gout medicines, but this has not become routine prescribing guidance.
History
Doctors had long recognized families in which several relatives had unusually low uric acid levels and a tendency toward kidney problems after intense exercise. In the early 2000s, researchers linked many of these cases to the SLC22A12 gene, helping clarify the cause of what is now called renal hypouricemia type 1. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition became an important example of how inherited kidney traits can be traced to one transporter gene. From these first observations, research expanded steadily. Studies from Japan and other countries were especially influential, because the condition had been described there more often and certain variants were found more frequently in those populations.